Coenzyme Q10 Ameliorates Ultraviolet B Irradiation Induced Cell Death Through Inhibition of Mitochondrial Intrinsic Cell Death Pathway by Jing, Li et al.
Int. J. Mol. Sci. 2011, 12, 8302-8315; doi:10.3390/ijms12118302 
 





Coenzyme Q10 Ameliorates Ultraviolet B Irradiation Induced 
Cell Death Through Inhibition of Mitochondrial Intrinsic Cell 
Death Pathway 
Li Jing 
1,2, Santosh Kumari 
1, Natalia Mendelev 
1 and P. Andy Li 
1,* 
1  Department of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technological 
Enterprise (BRITE), North Carolina Central University, Durham, NC 27707, USA;  
E-Mails: ljing@nccu.edu (L.J.); fkumari@NCCU.EDU (S.K.); nmendelev@nccu.edu (N.M.) 
2  Department of Pathology, Ningxia Medical University, Yinchuan, Ningxia 750004, China 
*  Author to whom correspondence should be addressed; E-Mail: pli@nccu.edu;  
Tel.: +1-919-530-6872; Fax: +1-919-530-6600. 
Received: 23 August 2011; in revised form: 8 October 2011 / Accepted: 21 November 2011 / 
Published: 24 November 2011 
 
Abstract: Ultraviolet B (UVB) induces cell death by increasing free radical production, 
activating apoptotic cell death pathways and depolarizing  mitochondrial  membrane 
potential.  Coenzyme Q10  (CoQ10), an essential cofactor in the mitochondrial  electron 
transport chain, serves as a potent antioxidant in the mitochondria. The aim of the present 
study is to establish whether CoQ10 is capable of protecting neuronal cells against UVB-
induced damage. Murine hippocampal HT22 cells were treated with 0.01, 0.1 or 1 µM of 
CoQ10  3 or 24 h prior to the cells being exposed to UVB irradiation. The CoQ10 
concentrations were maintained during irradiation and 24 h post-UVB. Cell viability was 
assessed by counting viable cells and MTT conversion assay. Superoxide production and 
mitochondrial membrane  potential were measured using fluorescent probes. Levels of 
cleaved caspase-9, caspase-3, and apoptosis-inducing factor (AIF) were detected using 
immunocytochemistry  and  Western blotting. The results showed that UVB irradiation 
decreased cell viability and such damaging effect was associated with increased superoxide 
production, mitochondrial depolarization, and activation of caspase-9 and caspase-3. 
Treatment with CoQ10 at three different concentrations started 24 h before UVB exposure 
significantly increased the cell viability. The protective effect of CoQ10 was associated 
with  reduction in superoxide production, normalization of mitochondrial membrane 
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potential and inhibition of caspase-9 and caspase-3 activation. It is concluded that the 
neuroprotective effect of CoQ10 results  from  inhibiting oxidative stress and blocking 
caspase-3 dependent cell death pathway. 
Keywords:  apoptosis; caspase; cell death pathway; coenzyme Q10; mitochondria; 
ubiquinone 10; ultraviolet 
 
1. Introduction  
Ultraviolet (UV) spectrum has both beneficial and detrimental effects on human health. Although 
UVB (280 to 315 nm) represents only 4% of the total solar UV radiation, it is responsible for most of 
the medical conditions related to sun exposure. Increasing evidence indicates that the body response to 
UVB is a complex and multifaceted biological process. UVB triggers signal transduction at multiple 
intracellular sites and the crosstalk between dedicated molecular mediators acting within a complex 
signal network determines the fate of UVB irradiated cells. Even if little is known about the signaling 
mechanisms that are triggered by UVB in keratinocytes, it is well established that the detrimental 
effects of this type of irradiation are associated with the formation of reactive oxygen species   
(ROS) [1,2]. Several cytokines, growth factors, hormones, and neurotransmitters use ROS as 
secondary messengers in the intracellular signal transduction [3]. Conversely, at high concentrations, 
ROS are prone to cause damage and are thereby potentially toxic, mutagenic or carcinogenic due to 
their high reactivity [4,5]. All major groups of bio-molecules can be damaged by ROS-catalyzed 
reactions, undergoing structural and functional modifications. Although only retinal neurons among 
the neuronal cells have the chance to be exposed to UV light, UV irradiation has been employed as a 
useful model to study ROS-mediated pathophysiology in various cell types, including neurons. Our 
previous studies have shown that UVB induces cell death by increasing production of ROS, inducing 
mitochondrial membrane depolarization and activating mitochondria-initiated apoptotic cell death 
pathways that include activation of caspases-9 and -3 [6,7]. 
Coenzyme Q10  (CoQ10), a fat-soluble, vitamin-like benzoquinone compound, is the electron 
acceptor for complex I and II. CoQ10 is a potent antioxidant, a membrane stabilizer, and a cofactor in 
the production of adenosine triphosphate (ATP) by oxidative phosphorylation. CoQ10 is also known as 
ubiquinone-10 or ubiquinol-10, a crucial component in mitochondrial oxidative phosphorylation and 
ATP production [8]. CoQ10 is identified in the mitochondria, lysosomes, Golgi and plasma membranes, 
where it functions as an antioxidant either by direct reaction with free radicals or by regeneration of 
tocopherol and ascorbate from their oxidized state [9]. Loss of CoQ10 causes cardiac failure and 
mitochondrial defects [10]. Previous studies have shown that either intraocular or oral administration 
of CoQ10 or in combination with vitamin E minimizes the glutamate toxicity and protects retinal 
ganglion cells from retinal ischemia/reperfusion induced damage in rats [11]. CoQ10 ameliorates UVA 
induced damage in human keratinocytes through reduction of ROS accumulation and prevention of 
DNA damage [12]. The aim of this study was to define the mechanisms by which CoQ10 protects cells 
against UVB induced damage. Int. J. Mol. Sci. 2011, 12  8304 
 
2. Results and Discussion 
2.1. Effect of CoQ10 on UVB Irradiation Induced HT22 Cells Death 
To investigate the effect of CoQ10 on UVB-induced damage to HT22 cells, numbers of viable cells 
were counted in non-UVB-challenged (Figure 1A), UVB-challenged (Figure 1B), dimethyl sulfoxide 
(DMSO)-treated (Figure 1C), and CoQ10-treated HT22 cells (Figure 1D–F). UVB irradiation reduced 
the viable cells from 84,000 ± 13,456.62/mL to 24,800 ± 8043.63/mL, nearly a 75% reduction 
compared with non-UVB treated cells (p < 0.01). Addition of 0.1% DMSO did not influence of the cell 
survival rate after UVB-irradiation. Treatment with CoQ10 at a concentration of 0.01, 0.1 or 1 µM  
24 h prior to UVB exposure and maintaining the same concentration for 24 h after UVB significantly 
increased the number of viable cells. As a result, at 24 h following UVB irradiation close to 50–60%  
of the HT22 cells was viable in CoQ10 treated cells (p  < 0.05 vs.  non-CoQ10 treated, UVB   
irradiated cells).  
Figure 1.  Cell viability after CoQ10 treatment in UVB exposed HT22 cells. UVB 
irradiation induced a significant reduction of cell viability (B,C) compared to control (A). 
Pretreatment with CoQ10 at 0.01, 0.1 or 1 µM improved cell viability at 24 h after UVB 
(D–F). Bar graph (G) represents 3 independent experiments, each performed in triplicate. 
# p < 0.01 vs. non-UVB control and * p < 0.05 vs. UVB. One-way ANOVA followed by 
Tukey’s test. Data are presented as means ± s.d. 
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2.2. Influence of CoQ10 on Mitochondrial Succinate Dehydrogenase Activity 
The  mitochondrial  succinate dehydrogenase enzyme activity  was detected using MTT assay.   
UVB-irradiation resulted in a significant decrease of MTT reduction, indicating a decrease of 
metabolically active mitochondria (Figure 2B) compared to Non-UVB control (Figure 2A). Addition 
of 0.1% DMSO did not protect HT22 cells from UVB induced damage (Figure 2C). Pre-treatment with 
CoQ10 initiated at 3 h prior to, and maintained for 24 h after, UVB irradiation, did not provide 
protection to mitochondria, as reflected by low conversion of MTT (data not shown). Similarly, MTT 
reduction remained as low as vehicle-treated cells if CoQ10 was only added at 24 h prior to UVB and 
discontinued after UVB exposure (data not shown). In contrast, CoQ10 pre-treatment initiated 24 h prior 
to, and maintained for 24 h after, UVB significantly intensified MTT reduction (Figure 2D–F). A 
summarized bar graph is given in (Figure 2G). 
Figure 2. MTT assay. UVB irradiation suppressed mitochondrial succinate dehydrogenase 
activity (B,C) compared to control (A). Pretreatment with CoQ10 at 0.01, 0.1 or 1 µM 
improved mitochondrial enzyme activity at 24 h after UVB (D–F). Bar graph (G) 
represents 3 independent experiments, each performed in triplicate. # p < 0.01 vs. non-
UVB control and * p < 0.05 vs. UVB. One-way ANOVA followed by Tukey’s test. Data 
are presented as means ± s.d. 
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2.3. Effects of CoQ10 on ROS Production and Mitochondrial Membrane Potential 
We measured ROS production using dihydroethidine (DHE)  probe that detects superoxide. As 
shown in Figure 3 left panel, UVB irradiation significantly enhanced the production of ROS (p < 0.05) 
and pretreatment with 1 µM CoQ10 prevented the UVB-induced ROS increase. Thus the levels of 
ROS were the same in CoQ10 treated cells as in non-UVB irradiated controls (p > 0.05). Similarly, 
mitochondrial membrane potential (Figure 3 right panel), which was measured using tetramethylrhodamine 
methyl ester (TMRM),  decreased in UVB-irradiated cells compared with normal control cells   
(p < 0.05), indicating mitochondrial membrane depolarization. Treatment with CoQ10 prevented the 
UVB-induced mitochondrial membrane depolarization. Therefore, the mitochondrial membrane 
potential in CoQ10-treated, UVB-irradiated cells was at the same level as in naïve control cells   
(p > 0.05).  
Figure 3. Measurements of ROS production by DHE (left column) and mitochondrial 
membrane potential by TMRM (right column). ROS bar graph demonstrates increases in 
ROS production after UVB and the anti-oxidative effect of CoQ10. Mitopotential bar 
graphs show mitochondrial membrane potential depolarization after UVB and preventive 
effect of CoQ10. Lower panels are representative original recordings. Data are collected 
form 3 independent experiments and presented as means ± s.d. * p < 0.05 against control. 
One-way ANOVA followed by Tukey’s test. 
 
2.4. Effect of CoQ10 on UVB Irradiation Induced Caspase-9 Activation 
Since CoQ10 is able to protect mitochondria, we decided to examine whether CoQ10 is capable of 
inhibiting mitochondria-initiated apoptotic cell death pathways that include activation of caspase-9 in 
the cytoplasm and nuclear translocation of apoptosis-inducing factor (AIF). Cleaved caspase-9 
antibody  was employed for immunocytochemisty and a set of representative photomicrograms is Int. J. Mol. Sci. 2011, 12  8307 
 
presented in (Figure 4A–F). No cleaved caspase-9 positive staining was observed in control cells 
without UVB challenge (Figure 4A). UVB-irradiation to cells cultured with normal medium (Figure 4B) 
or with addition of 0.1% DMSO (Figure 4C) induced a significant increased in caspase-9 positive cells 
(p < 0.01). The cleaved caspase-9 is localized in the cytoplasm (Figure 4C insert). Pretreatment with 
CoQ10 started 24 h prior to, and maintained for 24 h after, UVB (Figure 4D–F), significantly reduced 
the number of caspase-9 positively stained cells (p < 0.01) with no difference among the 3 dosages. 
Number of cleaved caspase-9 positively stained cells were counted per high magnification field (HPF) 
from 3 independent experiments, each performed in triplicate, and presented in (Figure 4H). Western 
blotting using caspase-9 antibody that detects both 49 KD full length caspase-9, and 39/37 KD cleaved 
caspase-9  further supports the findings observed in caspase-9 immunocytochemistry (Figure 4G). 
Thus, both the full length and a weak band of cleaved caspase-9 were observed in control cells 
cultured with or without 0.1% of DMSO. After UVB exposure, cleaved caspase-9 increased markedly. 
Pre-treatment with 1 μM Co-Q10 almost completely blocked the activation of caspase-9 (Figure 4G). 
Treatment with 0.01 μM and 0.1 μM achieved the same efficacy as 1 μM of Co10 on caspase-9 
inhibition (data not shown). 
AIF nuclear translocation was examined using anti-AIF antibody for immunocytochemistry. 
Although a few cells showed AIF positive staining in nuclei after UVB irradiation, such an increase 
did not reach statistical significance (data not shown). Number of AIF positively stained cells in 
CoQ10 treatment group was the same as UVB exposed cells (data not shown).  
2.5. Effect of CoQ10 on UVB Irradiation Induced Caspase-3 Activation 
Because cleaved caspase-9 activates caspase-3, the latter translocates into nucleus, causing DNA 
fragmentation and eventually cell death we decided to study whether CoQ10 blocks activation of 
caspase-3 in cells exposed to UVB. Cleaved caspase-3 (19/17 KD) was detected in UVB exposed cells 
treated with or without CoQ10  using immunocytochemistry and Western blotting. As shown in   
Figure 4, a few scattered caspase-3 positive cells were observed in control cells without UVB irradiation 
(Figure 5A–C). The location of the cleaved caspase-3 is in the nuclei (Figure 5C insert). The number of 
caspase-3 positive cells increased dramatically at 24 h following UVB irradiation, irrespective of 
DMSO was added or not (p < 0.01, Figure 5D–F). Treatment with CoQ10 (0.01, 0.1 or 1 μM) 24 h 
prior to, and maintained for 24 h after, UVB, significantly decreased the number of cleaved caspase-3 
positive cells (p < 0.05, Figure 5G–I). Although high dose of CoQ10 (1 μM) intend to have better 
effect than the medium (0.1 μM) and low doses (0.01 μM), the differences did not reach statistical 
significance.  Number of cleaved caspase-3 positively stained cells were counted per high 
magnification field from 3 independent immunocytochemistry experiments, each performed in 
triplicate, and presented in (Figure 5K). In agreement with the immunocytochemical finding, Western 
blot analysis using anti-caspase-3 antibody revealed that no cleaved caspase-3 in the nuclear fraction 
of the control non-UVB exposed cells with or without the presence of 0.1% DMSO in culture medium 
(Figure 5J). After UVB exposure, 19 and 17 KD cleaved caspase-3 increased markedly in the nuclear 
fraction and CoQ10 treatment initiated 24 h prior to, and maintained for 24 h after, UVB, significantly 
reduced the protein contents of activated caspase-3 (Figure 5J). The effect of CoQ10 on blocking 
caspase-3 activation was the same among all three tested dosages. Int. J. Mol. Sci. 2011, 12  8308 
 
Figure 4. UVB-activated caspase-9 is inhibited by CoQ10. A–F, Immunocytochemistry of 
cleaved caspase-9. Number of caspase-9 positive cells increased after UVB irradiation with 
or without 0.1% DMSO (B,C) compared to control (A). Pretreatment with CoQ10 at 0.01, 
0.1, or 1 M significantly reduced the number of caspase-9 positive cells (D–F). Green color 
represents cleaved caspase-9 staining and blue color denotes DAPI stained nuclei. Insert in 
Figure 3C shows cytosolic localization of cleaved caspase-9. G, western blotting showing 
full length (49 KD) and cleaved (39 KD) caspase-9 in control, UVB, and CoQ10 treated 
cells. Total and cleaved caspase-9 increased after UVB and CoQ10 pretreatment reduced 
both total and cleaved caspase-9 in the cytosolic fraction. H, Number of cleaved caspase-9 
positive cells per high magnification field counted from 3 independent immunocytochemistry 
experiments, each performed in  triplicate. #  p  <  0.01  vs.  non-UVB control and   
* p < 0.05 vs. UVB. One-way ANOVA followed by Tukey’s test. Data are presented as 
means ± s.d. HPF, high magnification field. 
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Figure 5. UVB-activated caspase-3 is inhibited by CoQ10. A–F, Immunocytochemistry of 
cleaved caspase-3. Number of caspase-3 positive cells increased after UVB irradiation (D-F) 
compared to control (A–C). Pretreatment with CoQ10 at 0.01, 0.1, or 1 M significantly 
reduced the number of caspase-3 positive cells (G–I). Green color represents cleaved 
caspase-3 staining and blue color denotes DAPI stained nuclei. Insert in Figure 5C shows 
nuclear localization of cleaved caspase-3. J, Western blotting showing cleaved caspase-3 
in control, UVB, and CoQ10 treated cells. The cleaved caspase-3 increased after UVB and 
CoQ10 pretreatment reduced the cleaved caspase-3 in the nuclear fraction. K, Number of 
cleaved caspase-3 positive cells per high magnification field counted from 3 independent 
immunocytochemistry experiments, each performed in  triplicate. #  p  <  0.01  vs.  
non-UVB control and * p < 0.05 vs. UVB. One-way ANOVA followed by Tukey’s test. 
Data are presented as means ± s.d. 
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2.6. Discussion 
Neuronal cells depend on mitochondrial oxidative phosphorylation for most of their energy needs. 
ROS are produced as by-products during mitochondrial electron transport, putting neurons at a risk for 
oxidative stress. Previous published studies, including ours, have demonstrated that UVB irradiation 
triggers neuronal HT22 cell death by enhancing ROS production, causing mitochondrial membrane 
potential depolarization, and activating mitochondria-initiated apoptotic cell death pathway [6,13]. The 
findings of the present study agree with previous published data showing that UVB irradiation reduces 
number of viable cells,  inhibits the reduction of MTT, increases ROS production and causes 
mitochondrial membrane potential depolarization, suggesting that UVB induces cell death by affecting 
mitochondria. Further studies revealed that cleaved caspase-9 in the cytosolic fraction and cleaved 
caspase-3 in the nuclear fraction increased markedly after UVB exposure, implying UVB induced cell 
death is mediated through mitochondria-initiated apoptotic cell death pathway. A weak 39 KD cleaved 
caspase-9 band was observed in non-UVB exposed cells with or without DMSO. However, since there 
was no subsequent cleavage of caspase-3 observed, the meaning of the caspase-9 presented in non-
UVB exposed cells is not clear. It is possible that the cleaved caspase-9 reflects a small number of 
cells undergoing apoptosis in baseline culture condition. 
CoQ10 serves as both an electron transporter in the mitochondrial electron transport chain and a 
free radical scavenger. CoQ10 has been shown to attenuate UV-induced apoptosis, accumulation of ROS, 
and activation of caspase-3 in human cells harboring large-scale deletion of mitochondrial DNA [14].  
In addition, prevention of apoptosis in keratinocytes by Co-Q10 is accompanied by inhibition of 
mitochondrial depolarization, cytochrome  c  release and caspase-9 activation, and such effects on 
mitochondria seems independent of CoQ10’s antioxidant property [15]. In the present study, we have 
shown that pretreatment with CoQ10 attenuated UVB-induced cell death. Thus, a partial response 
observed at 0.01 µM of CoQ10, which does not increase further with 1 µM of CoQ10. This suggests 
that the threshold for CoQ10 protection is below 0.01 µM. Future study has to use a dose range 
between 0.1–1 nM to satisfy the dose response curve fully. The protective effects of CoQ10 have been 
extensively studied in keratinocytes; however, its protective effects have not been well studied in 
neurons. In primarily cultured human keratinocytes collected from young and old donors, CoQ10 
reduces UV-induced wrinkles by combating the age-related energy metabolism shifts that include a 
higher glucose uptake and lactate production [16], accelerating the production of laminin, a basement 
membrane component [17], and inhibiting the production of inflammatory cytokine IL-6 and matrix 
metalloproteinase 1 (MMP-1) [18]. The neuroprotective effects of CoQ10 have only been the focus of 
attention in the last 10 years. Studies from Dr. Pandy’s group in Canada have shown that water soluble 
CoQ10  protects hydroperoxide induced apoptosis in human teratocarcinoma NT2 cells and human 
neuroblastoma SH-SY5Y cells by reducing mitochondrial ROS generation, stabilizing mitochondrial 
membrane potential, reducing caspase-3 activity and attenuating the fall of ATP production [19]. In 
animal models of Parkinsonism induced by paraquat that is known to cause dopaminergic 
neurodegeneration, water soluble CoQ10 administrated prior to,  or during,  the paraquat treatment 
completely blocked the detrimental effects of paraquat on neuronal loss in the substantia nigra region 
and neurobehavioral deficit [20]. Similar results have also been observed in rotenone-induced 
Parkinsonism [21]. Diet supplementation of CoQ10 to aged transgenic mice with mutations in the Int. J. Mol. Sci. 2011, 12  8311 
 
amyloid precursor protein delayed brain atrophy defined by the volume change of the hemispheres and 
hippocampi measured using magnetic resonance image in vivo [22]. The molecular signaling pathways 
leading to neuroprotection  of CoQ10 may involve inhibitions of BAX-induced mitochondrial 
dysfunction [23] and NFкB dependent pro-inflammatory gene expression [24]. In the present study, we 
demonstrate that CoQ10 protects neuronal cells from UVB-induced cell death by blocking activation 
of caspase-9 and -3, suggesting CoQ10 blocks mitochondria-initiated cell death pathway. It is not clear 
whether CoQ10 inhibits caspase-9 and -3 directly. We postulate that CoQ10 may inhibit the activation 
of caspase-9 and -3 by blocking upstream factors that cause the activation of these caspases. This is 
supported by our results showing that CoQ10 reduces ROS accumulation and prevents mitochondrial 
membrane depolarization in cells exposed to UVB. As is well known, mitochondrial depolarization 
opens mitochondrial permeability transition pore that allows release of certain mitochondrial proteins, 
causing activations of caspase-9 and, subsequently, caspase-3.  
3. Material and Methods 
3.1. Materials 
Drugs and sources were as follows: Dulbecco’s modified Eagle’s medium (DMEM), phosphate 
buffered saline (PBS), Fetal bovine serum (FBS), Trypsin-Versene Mixture, L-Glutamine and 
Penicillin-Streptomycin solution were purchased from HyClone laboratories (USA). CoQ10,  was 
purchased from Sigma-Aldrich (USA),  dissolved in DMSO  (Mediatech, USA) and diluted in   
culture medium. 
3.2. Cell Culture, UVB Irradiation and CoQ10 Treatment 
Murine hippocampal HT22 neuronal cells were cultured in DMEM containing 10% FBS, 2 mM 
glutamine, and 200 mM streptomycin/penicillin and then maintained at 90%–95% relative humidity in 
5% CO2 at 37 °C. The culture medium was renewed every 3 days. Cells (80,000 to 15,000) were 
seeded in 12-well or 96-well cell culture plates and incubated in the above medium for at least 24 h in 
CO2 incubator to allow the cells reaching 80% confluence. Prior to UVB irradiation, the cultures were 
washed twice with PBS to remove residual serum and nonattached cells. Cells were incubated for 1 
hour in serum-free medium and then exposed to 7 mJ/cm
2 dose of UVB radiation with a Fisher UV 
Transilluminator FB-TI-88A. The UVB dose energy is calculated by UV intensity multiplying time of 
exposure. This dosage was chosen based on our previous study showing 50–70% cell death at 24 h post-
exposure [13]. After UVB radiation, cells were returned to the culture incubator for 24 h of recovery at 
37 °C. Three CoQ10 treatment protocols (each with concentrations of 0.01, 0.1 and 1 µM) were used: 
(1) CoQ10 was given 24 h prior to UVB and maintained during 3 min UVB; (2) CoQ10 was treated 24 
h prior to UVB and maintained during UVB and 24 h post-UVB; (3) CoQ10 was given 3 h prior to 
UVB and maintained during UVB and 24 h post-UVB. 0.1% DMSO treated cells were used as control. 
3.3. Cell Viability Assay 
At 24 h after termination of UVB irradiation, numbers of viable cells in 12-well plates were counted 
using Beckman Coulter Vi-Cell Automated Cell Viability Analyzer (WS-VICELL), which uses trypan Int. J. Mol. Sci. 2011, 12  8312 
 
blue exclusion principle. The percent of cell viability was calculated and presented. All experiments 
were performed in triplicate and repeated in at least three separate experiments.  
3.4. Mitochondrial Succinate Dehydrogenase Activity 
Mitochondrial succinate dehydrogenase activity was measured in vehicle and CoQ10 treated murine 
hippocampal neuronal HT22 cells using 3-(4,5,-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) conversion assay. Since conversion of yellow MTT to purple formazan requires succinate 
dehydrogenase and depends on the activity of the respiratory chain and state of redox mitochondria, 
MTT assay can be used to determine mitochondria activity, in addition to serve as a measure of cell 
viability. The cells were prepared for MTT staining after 24 h of recovery in 96-well plates following 
UVB injury. MTT (final concentration, 0.25 mg/mL) was added to the medium 2 h prior to   
pre-determined end-point and incubated for 4 h in 37 °C in dark. After incubation, cells were lysed in 
50 µL DMSO that enables the release of dark purple reaction product, formazan. Absorbency at the 
wavelength 570 nm was read on an ELISA plate reader (Molecular Device, San Jose, USA). The 
results were expressed as a percentage of absorbency relative to control values.  
3.5. Measurements of Superoxide and Mitochondrial Membrane Potential 
Intracellular ROS (superoxide anion) production was measured using DHE probe  in  Co-Q10-
pretreated cells exposed to UVB for 24 h. Briefly, cells (2 × 10
6/mL) were incubated with the DHE 
(2.5 μM) for 30 min at 37 °C. Cells were washed, resuspended in phosphate buffered saline (PBS) and 
analyzed for fluorescence intensity using Fluoromax-4 spectroflorometer (HORIBA Jobin Yvon Inc, 
Edison, NJ) at the excitation and emission wavelengths of 480 nm and 590 nm respectively. The 
florescence recorded was represented as relative fluorescence intensity (RFI). Mitochondrial membrane 
potential was measured using the tetramethylrhodamine methyl ester (TMRM). Briefly, cells (1 × 10
6/mL) 
were harvested and incubated with 30 nM TMRM at 37 °C for 1 h. Cells were washed in PBS and 
fluorescence measurement was performed with a Fluoromax-4 spectroflorometer (HORIBA Jobin 
Yvon Inc, Edison, NJ) at excitation and emission of 530 and 573 nm respectively. Mitochondrial 
potential was dissipated with carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP 5 µM) and 
used as a positive control. 
3.6. Western Blot Analysis 
At 24 h following UVB treatment, cells were collected and lysed on ice in lysis buffer containing 
20 mM Tris pH7.4, 10 mM KCl, 3 mM MgCl2, 0.5% NP40 and complete inhibitors (Millipore). 
Lysates were centrifuged at 500 g for 10 min and resulted in a supernatant (S1) and a pellet (P1). The 
S1 fraction was centrifuged at 20,000 g  for 20 min and the resulting supernatant was used as a 
cytosolic fraction. The P1 fraction was washed twice with lysis buffer and resuspended in lysis buffer 
containing 1%SDS. The resulting lysates were sonicated briefly (Misonix, Ultrasonic Cell Disrupter) 
and then centrifuged at 20,800 g for 30 min. The resulting supernatants were designated as nuclear 
fractions. The purity of different cellular fractions has been tested previously [7]. Protein contents from 
each sample were measured using Microplate BCA Protein Assay Kit (Thermo Scientific). Equal Int. J. Mol. Sci. 2011, 12  8313 
 
amount of protein (20 µg) was loaded into each lane, separated in 10% NuPAGE BT gels (Invitrogen), 
transferred to PVDF membrane (Millipore), and probed with antibodies against AIF (D-20, Santa 
Cruz, 1;1000 dilution), caspase-3 (8G10, Cell Signaling, 1:1000 dilution) or caspase-9 (D353, Cell 
Signaling, 1:1000 dilution). 
3.7. Immunocytochemistry 
HT22 cells were fixed in 4% paraformaldehyde for 20 min at room temperature and processed for 
immunocytochemistry. After permeabilization with 0.1% Trinton X-100, the cells were incubated 
overnight at 4  °C with the polyclonal anti-AIF antibody (D-20, Santa Cruz, 1:300 dilution), 
monoclonal anti-cleaved caspase-3 antibody (ASP175,Cell Signaling:1:200 dilution) or polyclonal 
anti-cleave caspase-9 antibody (ASP353, Cell Signaling:1:50 dilution) followed by incubation with a 
secondary donkey anti-goat Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA) or donkey anti-rabbit 
Alexa Fluor 488 conjugate (Invitrogen) for 1 h at room temperature. The specimens were mounted 
with Vectashield Hardset Mounting Media (H-1200)  containing DAPI and examined using a 
fluorescence confocal microscope (Nikon Eclipse C1). Three microscopic fields at 400X were 
captured and number of positively stained cells was counted.  
3.8. Statistical Analysis 
Data are presented as means ± s.d. One-way ANOVA followed by Tukey’s test was used for 
statistical analysis. A value of p < 0.05 was considered statistical significant. 
4. Conclusion 
Our results show that UVB irradiation induces cell death by targeting mitochondria and activating 
mitochondria-initiated cell death pathway involving caspase-9 and -3. Pretreatment with CoQ10 at 
0.01, 0.1 or 1 µM initiated 24 h prior to, and maintained for 24 h after, UVB exposure, significantly 
increases cell viability by reducing ROS production, stabilizing mitochondrial membrane potential and 
blocking the activations of caspase-9 and caspase-3.  
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